Summary of G6PD activity stratified by gender^*.

<p>Summary of G6PD activity stratified by gender^{<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0157666#t002fn001" target="_blank">*</a>}.</p

Monthly incidences of malaria cases from January 2010 till October 2015 in Udupi district, Karnataka, India.

<p>Monthly incidences of malaria cases from January 2010 till October 2015 in Udupi district, Karnataka, India.</p

Percentage distribution of Rotavirus-positivity among hospitalalized infants <2 yrs age suffering from severe diarrhea in Patna.

<p>(A-B) Temporal distribution of Rotavirus positivity: data of 2 consecutive years (A) and age wise stratified data among all patients (B). (C) Breast-feeding wise distribution of Rotavirus positivity among all patients.</p

Comparison of survival hazard function between nPCR proven monoinfection <i>P</i>. <i>vivax</i> and mixed malaria cohorts.

<p>Comparison of survival hazard function between nPCR proven monoinfection <i>P</i>. <i>vivax</i> and mixed malaria cohorts.</p

Geographical location of PHCs within Udupi taluk, Karnataka, India.

<p>[Image: USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): <a href="http://earthexplorer.usgs.gov/" target="_blank">http://earthexplorer.usgs.gov/</a>].</p

Trend of parasitaemia and fever clearance in a cohort (N = 161) of <i>P</i>. <i>vivax</i> monoinfection patients from PHCs of Udupi taluk in southwestern India treated with chloroquine (1500 mg over 3 days) and primaquine (210 mg over 14 days).

<p>Trend of parasitaemia and fever clearance in a cohort (N = 161) of <i>P</i>. <i>vivax</i> monoinfection patients from PHCs of Udupi taluk in southwestern India treated with chloroquine (1500 mg over 3 days) and primaquine (210 mg over 14 days).</p

Relation of breast feeding status with Rotavirus infection and related outcome.

<p>(A) Breast-feeding wise distribution of Rotavirus positivity among all patients. (B, D-E) Age stratified data among breastfed and non-breastfed infants for Rotavirus positivity (B), Rotavirus antigenemia (D), and Rotavirus RNAemia (E). (C) Percentage positivity for Rotavirus antigenemia and Rotavirus RNAemia among breastfed and non-breastfed infants of the study.</p

Correlation of Rotavirus antigenemia and RNAemia with stool viral load.

<p>(A-D) Correlation of stool viral load with Rotavirus antigenemia (A,B) and Rotavirus RNAemia (C,D) in acute-phase (A,C) and convalescent phase (B,D) serum of infants suffering from acute gastroenteritis and diarrhea. Paired acute-phase and convalescent phase sera were tested for (i) Rotavirus antigenemia levels, that is denoted by levels of Rotavirus antigen (optical density/O.D.) measured by RV-EIA at 450 nm X 1000 units and (ii) Rotavirus RNAemia levels, denoted by levels of Rotavirus RNA in form of VP7 gene in reverse-transcriptase PCR calculated by band scanning software, as mentioned in the text. Stool viral load is represented by C(t) values in real-time RT-PCR.</p

Rotavirus antigenemia levels among the study groups.

<p>(A-C) Data demonstrates level of Rotavirus antigenemia in acute-phase (A) and convalescent phase (B) sera in infants suffering from severe diarrhea in comparison with the healthy control group. Paired acute-phase and convalescent phase sera were tested for Rotavirus antigenemia levels, that is denoted by levels of Rotavirus antigen (optical density/O.D.) measured by RV-EIA at 450 nm X 1000 units, as mentioned in the text. Broken lines denote the cut-off value.</p